Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A00020-51 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main objective of the study is to determine the intra-prostatic concentration of sexual steroids when castration resistance appears in castration-resistant prostate cancer patients compared to patients naif of hormonal treatment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| prostate cancer patients resistant to castration | Experimental |
| |
| patients naif of hormonal treatment | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| intra-prostatic concentration of sexual steroids | Biological |
| ||
| Measure | Description | Time Frame |
|---|---|---|
| intra-prostatic concentration of sexual steroids | 2 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Androgen receptor immuno-histochemical expression level | 2 weeks | |
| Androgen receptor RNA expression level | 2 weeks | |
| Steroid 5-alphareductase immuno-histochemical expression level |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yann NEUZILLET, MD | Hopital Foch | Principal Investigator |
| Henry Botto, MD | Hopital Foch | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Foch | Suresnes | 92150 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Trans-rectal biopsy |
| Procedure |
|
| 2 weeks |
| Steroid 5-alphareductase RNA expression level | 2 weeks |
| Steroid aromatase immuno-histochemical expression level | 2 weeks |
| Steroid aromatase RNA expression level | 2 weeks |
| D005832 |
| Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |